Middle East respiratory syndrome (MERS) is caused by a virus that does not encode any neuraminidase proteins - VCE - SSCE Biology - Question 38 - 2021 - Paper 1
Question 38
Middle East respiratory syndrome (MERS) is caused by a virus that does not encode any neuraminidase proteins. This means that the antiviral drug Relenza would
a. re... show full transcript
Worked Solution & Example Answer:Middle East respiratory syndrome (MERS) is caused by a virus that does not encode any neuraminidase proteins - VCE - SSCE Biology - Question 38 - 2021 - Paper 1
Step 1
a. reduce the number of MERS viral particles released from infected cells.
96%
114 rated
Only available for registered users.
Sign up now to view full answer, or log in if you already have an account!
Answer
Relenza primarily targets neuraminidase proteins, which are not present in MERS. Therefore, it would not effectively reduce MERS viral particles.
Step 2
b. be useful to consider as a prevention method against MERS infections.
99%
104 rated
Only available for registered users.
Sign up now to view full answer, or log in if you already have an account!
Answer
Since Relenza does not target a relevant mechanism for MERS, it would not be considered useful as a preventive measure.
Step 3
c. be unlikely to improve the recovery of MERS-infected patients.
96%
101 rated
Only available for registered users.
Sign up now to view full answer, or log in if you already have an account!
Answer
Given that Relenza targets neuraminidase and MERS does not encode this protein, it is unlikely to enhance recovery for infected patients.
Step 4
d. target other cell surface proteins of MERS-infected cells.
98%
120 rated
Only available for registered users.
Sign up now to view full answer, or log in if you already have an account!
Answer
Relenza is designed to inhibit neuraminidase, not to target other proteins. Thus, it would not target cell surface proteins of MERS-infected cells.
